Nu-V3 Non-Invasive Nerve Stimulation Device Trial for Chronic Pain, Anxiety, Depression, Sleeplessness

NATerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 13, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

December 31, 2020

Conditions
Chronic PainAnxietyDepressionSleeplessness
Interventions
DEVICE

Nu-V3

The Nu-V3 device provides a continuous flow of intermittent, low frequency electrical pulses to the ear's specific cranial nerve endings. This treatment is delivered 24 hours a day for the first 12 weeks, then is delivered two weeks on, one week off for the following 12 weeks.

Trial Locations (1)

85053

Arizona Endocrinology, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nu-Life Solutions

INDUSTRY